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Spectinomycin remains a useful reserve option for therapy of gonorrhea. The emergence
of multidrug-resistant Neisseria gonorrhoeae strains with decreased susceptibility to
cefixime and to ceftriaxone makes it the only medicine still effective for treatment of
gonorrhea infection in analogous cases. However, adoption of spectinomycin as a routinely
used drug of choice was soon followed by reports of spectinomycin resistance. The
main molecular mechanism of spectinomycin resistance in N. gonorrhoeae was C1192T
substitution in 16S rRNA genes. Here we reported a Thr-24→Pro mutation in ribosomal
protein S5 (RPS5) found in spectinomycin resistant clinical N. gonorrhoeae strain, which
carried no changes in 16S rRNA. In a series of experiments, the transfer of rpsE gene
allele encoding the mutant RPS5 to the recipient N. gonorrhoeae strains was analyzed.
The relatively high rate of transformation [ca. 10−5 colony-forming units (CFUs)] indicates
the possibility of spread of spectinonycin resistance within gonococcal population due to
the horizontal gene transfer (HGT).
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INTRODUCTION
Neisseria gonorrhoeae is an obligate pathogen causing gonor-
rhea, one of the most abundant sexually transmitted diseases.
The expansion of drug resistant N. gonorrhoeae strains is one of
the global contemporary problems. The emergence and spread-
ing of multidrug resistant (MDR) strains, which are resis-
tant to penicillin, tetracycline, and ciprofloxacin, are reported
throughout the world. In some countries, including Russia,
about 50% of clinical N. gonorrhoeae strains identified as MDR
(Kubanova et al., 2010; Allen et al., 2011). Until recently, all these
strains remain susceptible to spectinomycin and to extended-
spectrum cephalosporins (ceftriaxone and cefixime). Recently,
N. gonorrhoeae strains displayed reduced susceptibility to the
extended-spectrum cephalosporins. Moreover, several cases of
clinical failures during the cefixime treatment have been reported
(Wang et al., 2003; Heymans et al., 2012; Unemo et al., 2012).
The spectinomycin remains the only antibiotic still effective in
analogous cases. However, adoption of spectinomycin as the
routinely used drug of choice was soon followed by reports of
spectinomycin resistance (Boslego et al., 1987). The treatment of
gonorrhea infection caused by extremely drug resistant (XDR)
N. gonorrhoeae strains is very difficult, and the extended knowl-
edge of molecular mechanisms of drug resistance is required
for development of new tests needed to for routine diagnose in
clinical practice.
In general, these are several mechanisms occurring in the bac-
teria which confer them antibiotic resistance. The most common
are known to be drug inactivation, efflux-pumping of the drug
out of the cell, and target modification due to single nucleotide
change polymorphisms (SNPs)mainly (Davies andDavies, 2010).
A bacterial strain can acquire resistance either by mutation of
its own genes or by the uptake of exogenous genes by horizon-
tal transfer from other microbes. Within bacterial population
horizontal gene transfer (HGT) occurs via conjugation, transfor-
mation and transduction. With regards to neisseria genus these
bacteria are naturally transformable and are capable to exchange
their genetic material with high frequency (Koomey, 1998). This
property leads to the rapid dissemination of antibiotic resistance
markers and to the panmictic structure of the gonococcal and
meningococcal populations.
Spectinomycin belongs to an aminocyclitol antibiotic class
which blocks biosynthesis of bacterial proteins. After entering the
bacterial cells, spectinomycin binds a ribosome beneath the 34
helix of 16S rRNA and interrupts elongation of the polypeptide
during protein synthesis apparently preventing the translocation
of the peptidyl tRNA from the A-site to the P-site (Carter et al.,
2000; Borovinskaya et al., 2007).
Various bacteria demonstrate spectinomycin resistance, which
results from three different mechanisms. The most frequent
mechanism is the drug inactivation by adenylylation. Until
now a diverse number of adenyltransferases, which exhibit the
spectinomycin resistant (Spt-R) phenotype, was described (Shaw
et al., 1993). One group of enzymes referred as AAD(3′′)(9) [or
ANT(3′′)(9)] confers combined resistance to spectinomycin and
streptomycin. These enzymes were found in a variety of gram-
negative bacteria (Yamada et al., 1968; Hollingshead and Vapnek,
1985; Kehrenberg et al., 2005) and also in gram-positive bac-
teria (Clark et al., 1999). The other group of adenyltransferase
referred as AAD(9) [or ANT(9)] confers the Spt-R phenotype
only (LeBlanc et al., 1991).
On the other hand, the spectinomycin resistance can result
from alteration of 30S subunit of bacterial ribosome due to
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mutations in chromosomal genes encoding ribosomal RNAs or
proteins. Thus, mutations in the spectinomycin binding region
of helix 34 of 16S rRNA encompassing the cross-linked posi-
tions from 1063 to 1066 and from 1190 to 1193 (in Escherichia
coli numbering) lead to high level resistance to spectinomycin
(Sigmund et al., 1984; Brink et al., 1994). These mutations
were discovered for various bacteria such as Chlamydia psittaci,
Borrelia burgdorferi, E. coli, Pasteurella multocida (Johanson and
Hughes, 1995; Binet and Maurelli, 2005; Criswell et al., 2006;
Kehrenberg and Schwarz, 2007) including N. gonorrhoeae and
N. meningitidis (Maness et al., 1974; Galimand et al., 2000).
Although ribosomal protein S5 (RPS5) is not involved in specti-
nomycin binding, it is located very close to the antibiotic binding
site (within 5 A◦) (Wirmer and Westhof, 2006). Accordingly, it
has been found that mutations in RPS5 can lead to spectinomycin
resistance in E. coli (Funatsu et al., 1972; Bilgin et al., 1990) and
in P. multocida (Kehrenberg and Schwarz, 2007).
Until recently, the only 16S rRNA substitutions were found
in Spt-R bacteria from Neisseria genus (Maness et al., 1974;
Galimand et al., 2000). In this study, we reported the discovery
of isolated mutation in RPS5 in Spt-R clinical N. gonorrhoeae
strain, confirmed by Unemo et al. (2013), and estimate the poten-
tial of Spt-R horizontal spread. We established that the 10−5
colony-forming units (CFU) from transformation experiments
represents a high risk of spectinomycin resistance spread within
gonococcal population.
MATERIALS AND METHODS
BACTERIAL STRAINS
N. gonorrhoeae clinical isolates were collected as a part of previous
study (Ilina et al., 2008) and stored at a temperature of −80◦C.
The studied N. gonorrhoeae clinical isolates and strains are shown
in Table 1.
For any manipulations, gonococci were cultivated on the
BBL™ GC agar base (Becton Dickinson & Co, USA) sup-
plemented with 1% BBL™ IsoVitaleX™ Enrichment (Becton
Dickinson & Co, USA) at 37◦C in a humid atmosphere with 5%
CO2 during 20–24h.
PHENOTYPIC CHARACTERIZATION
Susceptibility testing to penicillin G, tetracycline, ciprofloxacin,
spectinomycin and ceftriaxone was performed by agar dilution
method in accordance with CLSI recommendations (CLSI doc-
ument M100-S17, 2007). All antibiotics were manufactured by
Sigma, USA. N. gonorrhoeae strain ATCC 49226 was used as a
control.
GONOCOCCAL TRANSFORMATION
Spot-transformation of gonococci was performed as described
(Dillard, 2011). Briefly, 200 ng of amplified DNA fragments in
a 10µl volume were placed into spots (diameter approximately
1.5 cm) on a pre-warmed (37◦C) GC base agar plate. The spot
was allowed to soak into the plate. Then piliated colonies of
N. gonorrhoeae recipient strains were streaked across the plate
through the DNA spots. After overnight incubation at 37◦C in
a humid atmosphere with 5% CO2, colonies were swabbed from
the spot with a Dacron swab and re-suspended in 100µl of stor-
agemedium (50% BBL™ BrainHeart Infusion, Becton Dickinson
& Co, USA, 30% Fetal Bovine Serum, Gibco, USA, 20% glycerin,
Sigma, USA). This suspension of cells was then diluted and plated
on both GC base agar alone, and GC base agar supplemented
with 64mg/L of spectinomycin. These plates were incubated at
37◦C in a humid atmosphere with 5% CO2 for one to two
days, and individual transformants were picked up from specti-
nomycin supplemented plate. Selected colonies were cultivated
once again on spectinomycin supplemented plates; the obtained
Table 1 | Characteristics of gonococci involved into current investigation.
Name Description MICs (mg/L) for Serotype NG-MAST
sequence type
PEN TET CIP SPT CRO
e03.04 Clinical isolate 0.015 < 0.03 0.001 32–64 < 0.002 P1B3 5187
NG3 Clinical strain derived
from e03.04 isolate
0.015–0.03 0.03–0.06 0.001–0.002 4–8 0.0005–0.001 P1B3 5187
NG3.1 Clinical strain derived
from e03.04 isolate
< 0.015 0.03–0.06 0.0005–0.001 64–128 0.0005–0.001 P1B3 5187
NG3.2 Clinical strain derived
from e03.04 isolate
0.03–0.06 0.03–0.06 0.0005–0.001 64–128 0.001–0.002 P1B3 5187
NG7 Clinical strain, using as a
recipient for
spot-transformation
0.12–0.25 0.015 0.001 16–32 0.002 P1B3 8633
NG94 Clinical strain, using as a
recipient for
spot-transformation
0.015–0.03 < 0.03 0.001 16–32 < 0.002 P1B3 8401
PEN, penicillin; TET, tetracycline; CIP, ciprofloxacin; SPT, spectinomycin; CRO, ceftriaxone.
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N. gonorrhoeae strains were stored at −80◦C. Transformation fre-
quency was calculated as the number of spectinomycin-resistant
colony-forming units (SPTr CFU/ml) per total CFU (CFU/ml).
GENOTYPIC CHARACTERIZATION USES FEW METHODS: PCR AND
SEQUENCING AND MALDI-TOF MS
Total genomic DNA from tested N. gonorrhoeae strains was iso-
lated by “DNA express” kit (Lytech Ltd, Russia). When necessary,
the prepared DNA samples were stored at a temperature of
−20◦C.
Conventional PCR was done using the genomic DNA as
a template and oligonucleotide primers described in Table 2.
All primers were newly designed using the Oligo_6.31 soft-
ware (Molecular Biology Insights Inc., USA) and sequences of
N. gonorrhoeae strain FA1090 (GenBank accession number is
NC_002946). Amplification was carried out in 10µl of 66mM
Tris-HCl pH 9.0; 16.6mM (NH4)2SO4; 2.5mM MgCl2; 0.2mM
of each dNTP; 5 pmol of each primer (Table 2) and 1 unit of
TaqPolymerase (Fermentas, Lithuania) under the following con-
ditions: 94◦C for 20 s, 60◦C for 20 s, and 72◦C for 15 s, in 35
cycles. A programmed thermocycler TETRAD DNA ENGINE
(MJ Research Inc.) was used. The amplification products were
analyzed by electrophoresis in 2% agarose gel.
For further sequencing analysis dephosphorylation of the
5′-end phosphate groups of dNTPs and cleavage of primers
in the post-amplification reaction mixture was done by incu-
bation with 0.5U of shrimp alkaline phosphatase and 0.1U
of exonuclease I (both enzymes from Fermentas, Lithuania)
for 20min at 37◦C, followed with inactivation by heating at
85◦C for 10min. Sequence analysis of 16S rRNA genes as well
as genes cording the ribosomal proteins S5, S4, and S8 was
performed with dedicated primers (Table 2) by the modified
Sanger method using the ABI Prism™ BigDye® Terminator v.
3.1 Cycle Sequencing Kit and 3730xl DNA Analyzer (Applied
Biosystems, USA) according to the manufacturer’s instruction.
Analysis of the nucleotide sequences as well as deduced amino
acid sequences was done using the Vector NTI Advance v. 9.0
software (Infomarks Incorporation, USA).
N. gonorrhoeae multi-antigen typing (NG–MAST) was per-
formed as originally described (Martin et al., 2004). Sequence
types were identified via NG-MAST (http://www.ng-mast.net)
websites.
The rapid identification of A70C nucleotide substitution in
rpsE gene, leading to Thr-24→Pro amino acid mutation in RPS5,
was done by primer extension reaction followed by MALDI ToF
mass spectrometry. For this, PCR was performed as mentioned
above with primers form Table 2. The dephosphorylation of the
5′-end phosphate groups of dNTPs in the post-amplification reac-
tion mixture was carried out by incubation with 0.5U of shrimp
alkaline phosphatase (Fermentas, Lithuania) for 20min at 37◦C,
followed by inactivation of the enzyme by heating for 10min at
85◦C. After that amplicon was used as template in thermocyclic
primer extension reaction, carried out in 20µL of the mixture of
66mM Tris-HCl pH 9.0; 16.6mM (NH4)2SO4; 2.5mM MgCl2;
Table 2 | List of primers selected for PCR and sequencing of N. gonorrhoeae genes encoding 16S rRNAs, and ribosomal proteins S4, S5, and S8.
Genetic characterization of selected N. gonorrhoeae strains
Target Primers for PCR, 5′-3′ sequence(amplicon length) Primers for sequencing, 5′-3′ sequence
1st copy of 16S rRNA aaccgatgaccccctgcttg; gaaaaatgcatggcaggccg (2194bp) aaccgatgaccccctgcttg
tgacgtgtgaagccctggtcataa
acgctaccaagcaatcaagttgcc
tcatcggccgccgatattggcaac
2nd copy of 16S rRNA aaccgatgaccccctgcttg; accgtaaccgaatgcccctg (2409bp)
3rd copy of 16S rRNA aaccgatgaccccctgcttg; gcaaacccatgacatttacc (2435bp)
4th copy of 16S rRNA aaccgatgaccccctgcttg; acgggatcgggaacgaaaac (2432bp)
RPS4 (rpsD gene) tattaaaggtccaggtccaggtcg; catggatgacagtaagatacggcg (954bp) as for PCR
RPS5 (rpsE gene) cgtgcacatgcacgatgagattca; tgagaaggctaaagcagcaggtgt (727 bp) as for PCR
RPS8 (rpsH gene) tcaatccattcctcgtaatgcggc; tttacttctacaccagcgggaacc (637 bp) as for PCR
Genomic DNA fragment
for spot transformation
tcaaagcaactgtaggtcgg; tgcgttctggtgctaaaggc (12931bp)
Identification of RPS5 Thr-24→Pro mutant strains
Target Primers for PCR, 5′-3′
sequence (amplicon
length)
Primer for primer
extension
(minisequencing)
reaction, 5′-3′
sequence, molecular
weight
Composition of
dNTP and ddNTP
mix
Predicted
molecular weight
of primer extension
reaction products
for wild type
Predicted
molecular weight
of primer extension
reaction products
for mutant type
A70C mutation
in rpsE gene
cgtgcacatgcacgatgagattca;
tgagaaggc-
taaagcagcaggtgt
(727 bp)
gacgacctttaactactttgg
(6397 Da)
dG, ddT 6685 Da
(primer + ddT)
7014 Da
(primer + dG +ddT)
The scheme of identification of A70C mutation in rpsE gene by primer extension reaction followed by mass spectrometry measuring is also presented.
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0.2mM of each dGTP and ddTTP, 10 pmol of internal primer (see
Table 2) and 2 units of TermiPol DNAPolymerase (Solis Biodyne,
Estonia) according to the followed profiling: 94◦C for 20 s, 58◦C
for 20 s, and 72◦C for 15 s, in 70 cycles.
The products from primer extension reaction were purified
using the SpectroCLEAN Kit (Sequenom, USA) according to the
manufacturer’s instruction.
An aliquote (0.2–1µL) of purified products from primer
extension reaction was spotted onto a matrix, which was prelim-
inarily dried on the MALDI target AnchorChip™ with 400µm
diameter of anchor sports (Bruker Daltonics, Germany). The
matrix employed was a saturated solution of 3-hydroxypicolinic
acid (Fluka, Germany) in a 1:1 acetonitrile/water mixture (Merck,
Germany) mixed with 0.4M dibasic ammonium citrate (Fluka,
Germany) in 9:1 vol. ratio. All solvents were of quality suitable for
mass spectrometry. Mass spectra were collected on a Microflex
LT MALDI ToF mass spectrometer (Bruker Daltonics, Germany)
that was operated in the positive linear mode. A 337 nm nitrogen
laser with the 9Hz pulse frequency was used. Mass spectrometer
parameters were optimized for the range of m/z values from 1000
to 10,000, using a peptide standards set for calibration. Each mass
spectrum was collected at 30 laser pulses at constant laser power
and constant threshold value, in order to enhance the resolution.
ACCESSION NUMBERS
DNA sequences of rspE gene alleles of N. gonorrhoeae strains
NG3, NG3.1, and NG3.2 were deposited into GenBank [accession
numbers KF021591, KF021592, and KF021593, respectively].
RESULTS AND DISCUSSION
In this study we identified a molecular mechanism responsible
for spectinomycin resistance in gonococci. As a part of unre-
lated experiment, N. gonorrhoeae strains with Spt-R phenotype
were occasionally isolated. They were derived from clinical iso-
late e03.04 belonged to Por1B3 serotype. Collected in 2004 it was
identified as susceptible to penicillin, tetracycline, ciprofloxacin,
and ceftriaxon. Spectinomycin MIC was defined as 32-64mg/L,
which corresponded to intermediate resistant (Spt-I) phenotype.
When the susceptibility profile of this isolate was retested in 2008
two colonies emerged on the plate supplemented with 64mg/L of
spectinomycin. Each colony was seeded once again on plates with
the same antibiotic concentration, and then on the plates with
128mg/L of spectinomycin. It was a poor growth on plates with
128mg/L of spectinomycin, so two clones grown well under the
64mg/L of spectinomycin were stored.
It should be noted that neither one of other N. gonorrhoeae
isolates tested in this experiment nor the same e03.04 clinical iso-
late examined in repeats revealed any additional colonies survived
under 64mg/L of spectinomycin. Thus we have considered two
occasionally isolated Spt-R clones as a small fraction of heteroge-
neous e03.04 clinical isolate. The collected strains were designated
as NG3.1 and NG3.2. Gonococci derived from e03.04 isolate
susceptible to spectinomycin treatment were also collected and
stored as NG3 N. gonorrhoeae clinical strain.
Susceptibility testing data for clinical e03.04 isolate as well
as for selected N. gonorrhoeae strains is presented in Table 1. In
accordance with NG-MAST scheme all of them belonged to the
same 5187 sequence type that supported the assumption of a
common origin of the strains studied. Since, the only previously
reported mechanism for Spt-R gonococci was C1192T muta-
tion in 16S rRNA gene (Maness et al., 1974; Galimand et al.,
2000), we have sequenced all four copies of 16S rRNA genes
located inN. gonorrhoeae genomic DNA (for the number of rRNA
genes copies see rrnDB database, http://ribosome.mmg.msu.edu/
rrndb/index.php). For each tested strain, all four copies of 16S
rRNA genes were found identical. Indeed, the 1192 position as
well as a locus encoding for the 34 helix of 16S rRNA, which forms
the spectinomycin-binding site of ribosome (Carter et al., 2000;
Wirmer and Westhof, 2006) possessed the wild-type sequence in
NG3 strain as well as in NG3.1 and NG3.2 ones. So, we have
proposed that other molecules located close by to the riboso-
mal spectinomycin-binding site could be involved in formation
of Spt-R phenotype.
The crystal structure of the 30S subunit of bacterial ribosome
from E. coli in complex with spectinomycin (Carter et al., 2000)
was taken into account and the ribosomal proteins S4, S5, and
S8 were picked up for further examination due to their vicin-
ity to a spectinomycin-binding site. Accordingly, rpsD, rpsE, and
rpsH genes were amplified and sequenced. No differences were
found between rpsD, and rpsH genes. However, both Spt-R N.
gonorrhoeae strains (NG3.1 and NG3.2) carried the same A70C
mutation in rpsE genes, leading to Thr-24→Pro amino acid sub-
stitution at RPS5, which mapped to Ser-22 residue of RPS5 from
E. coli (Figure 1).
The 19–33 loop of RPS5 is known to be RNA binding site,
and is the most frequent zone for location of mutations related
FIGURE 1 | Multiple alignment of RPS5 sequences of NG3,
NG3.1, and NG3.2 strains. The Thr-24→Pro mutation is bolded.
Deduced amino acid sequences of RPS5 of wild-type N.
gonorrhoeae (ATCC49226, FA1090), N. meningitidis (NM_MC58), E.
coli (EC_K12), and P. multocida (PM_1398) are also presented.
Regions involved in formation of resistance to spectinomycin are
underlined [according to Davies et al. (1998); Kehrenberg and
Schwarz (2007)].
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy July 2013 | Volume 4 | Article 186 | 4
Ilina et al. Resistance of N. gonorrhoeae to spectinomycin
to spectinomycin resistance (Funatsu et al., 1972; Wirmer and
Westhof, 2006; Kehrenberg and Schwarz, 2007). Mostly, RPS5
mutations associated with Spt-R phenotype occur simultaneously
with 16S rRNA changes. However, the isolated Ser-22→Pro RPS5
mutation in resistant to spectinomycine E. coli strain was also
described (Wilcox et al., 2001). Basing on this knowledge, we
have suggested that the Thr-24→Pro substitution found in RPS5
from NG3.1 and NG3.2 N. gonorrhoeae strains confer the Spt-R
phenotype.
As an argument, that the single Thr-24→Pro mutation in
RPS5 can support a Spt-R phenotype alone, we performed a
transformation of spectinomycin sensitive N. gonorrhoeae strains
by the exogenic DNA fragment contained mutant rpsE gene.
Furthermore, the experiments described below demonstrated a
potential role of HGT in spread of spectinomycin resistance.
The 12931 bp fragments of N. gonorrhoeae chromosomal
DNA, which include whole rpsE gene and the nearest DNAuptake
sequences (DUS12, 5′ atgccgtctgaa 3′) on their ends were ampli-
fied with primers indicated in Table 2. It was done using the NG3
(wild type) andNG3.1 (mutant) genomic DNAs as templates. The
presence of DUS12 is known to be necessary for DNA recognition
and uptake and therefore, mediates an increase in transformation
efficiency (Duffin and Seifert, 2010).
Two different N. gonorrhoeae strains—NG7, and NG94, sus-
ceptible to spectinomycin were chosen as recipients. For each
recipient, the spot transformation by purified amplified DNA
fragment contained mutant (or wild) variant of rpsE gene was
carried out. The principal scheme of an experiment is represented
in Figure 2. The transformation of recipients by a DNA fragment
carried a wild variant of rpsE gene was used as a negative control.
Each experiment was repeated in triplicate.
As a result, 74.7 ± 5.7 and 15.6 ± 2.5 colonies emerged on
GC agar plates supplemented with 64mg/L of spectinomycin
and derived from NG7 and NG94 bacterial cells transformed
by mutant rpsE gene, respectively (Table 3). Bacterial cells trans-
formed by DNA fragment carried wild type of rpsE gene formed
no colonies on spectinomycin supplemented GC agar plates.
Transformation frequency calculated as the number of SPTr CFU
per total CFU was found 2.2 ± 0.4 × 10−5 and 1.7 ± 0.2 × 10−5
for NG7 and NG94 N. gonorrhoeae strains, respectively.
Each transformant survived after a re-cultivation on specti-
nomycin supplemented (64mg/L) agar plates was tested by
sequencing. All tested strains carried A70C mutation in rpsE
gene identical to NG3.1 and NG3.2 N. gonorrhoeae strains
and leading to Thr-24→Pro amino acid substitution in RPS5.
Otherwise, in accordance with NG MAST, they belonged to the
same sequence types as the recipient strains from which they
originated.
The spectinomycin MICsweremeasured for the transformants
derived both from NG7 and NG94 N. gonorrhoeae recipient
strains. In all cases, spectinomycin MICs increased fourfold (from
16–32mg/L to 64–128mg/L) and became identical to the ones of
NG3.1 and NG3.2 N. gonorrhoeae strains.
Described experiments verified that single Thr-24→Pro
amino acid substitution in RPS5 confers the Spc-R phenotype of
N. gonorrhoeae strains.
FIGURE 2 | The principal scheme of sport transformation. Amplified DNA
fragments carried mutant (mut) and wild type (wt) of rpsE gene cording the
ribosomal protein S5 (RPS5) were placed in spots on a GC base agar plate.
Then piliated colonies of recipient strains (NG7 and NG94) were streaked
across the plate through the DNA spots. After overnight incubation, bacterial
cells were swabbed from the spots into a liquid medium, diluted and plated
on both GC base agar alone, and GC base agar supplemented with 64mg/L
of spectinomycin (SPT). The individual transformants emerged on
SPT-supplemented plates were picked up for further examination.
Colony-forming units (CFUs) were counted on each plate.
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Table 3 | The calculated results of transformation experiments.
Recipient Av. SPTr CFUs Av. SPTr CFU/ml Av total CFU/ml Transformation efficiency
NG7 74.7 ± 5.7 3.5 ± 0.4 × 104 1.6 ± 0.5 × 109 2.2 ± 0.4 × 10−5
NG94 15.6 ± 2.5 0.8 ± 0.2 × 104 4.7 ± 0.2 × 108 1.7 ± 0.2 × 10−5
An average data from three replicas is presented.
Furthermore, the transformation efficiency was found rela-
tively high (ca. 10−5) and was not statistically different between
both recipient strains. This finding supports the statement that
the HGT through the natural transformation permits movement
of mutant allele of rpsE gene and increases the opportunity for the
spread of spectinonycin resistance within gonococcal population.
The RPS5 mutation we verified here appeared to be the same
that was described for N. gonorrhoeae WHO A strain (Unemo
et al., 2013). This mutation results in low-level spectinomycin
resistance in gonococci that agrees with our conclusion.
The main issue is that in this study, conducted indepen-
dently the mutant allele of rpsE gene was found in clinical N.
gonorrhoeae strain isolated in Russia. This emphasizes that the
described molecular mechanism of Spt-R phenotype formation
is a universal one and spreads worldwide.
To extend the knowledge of frequency of RPS5 Thr-24→Pro
mutants the entire laboratory collection of N. gonorrhoeae
genomic DNA (n = 1131) acquired since 2002–2008 years was
analyzed. The majority of them (n = 1113) were susceptible to
spectinomycin, and the 18 strains revealed the Spt-I phenotype
(MICs = 32–64mg/L). Keeping in mind that NG3.1 and NG3.2
strains possessed Thr-24→Pro mutation in RPS5 were found
occasionally as a small fraction of a wild population, we did
not exclude susceptible to spectinomycin gonococci from the
examination.
No more mutant N. gonorrhoeae strains have been found.
It seems the tested Thr-24→Pro substitution in RPS5 is
very rare among gonococci. This may reflect the uncom-
mon use of spectinomycin in therapy of gonorrhea. On
the other hand, we cannot deny that gonococci with muta-
tion in ribosomal protein could be somehow defective in
their survival and population spreading. Undoubtedly, fit-
ness cost due to such mutation requires further careful
investigation.
Nevertheless, our study is an additional evidence of the exist-
ing of clinical N. gonorrhoeae strains with moderate spectino-
mycin resistance due to isolated mutations in RPS5. It is very
important in terms of the surveillance and the therapy of gono-
coccal infection. The extended knowledge of the potential muta-
tions responsible for resistant phenotypes is essential in the
development of new tests suitable in clinical setting, which aim
to establish the correct antimicrobial therapy.
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